Condition: Recurrent Ovarian Cancer · Sponsor: Lan Coffman
This is a clinical trial using CPI-0209 in combination with Carboplatin chemotherapy followed by CPI-0209 maintenance in patients with platinum sensitive, recurrent ovarian cancer.
This description comes directly from the study's public registry record.
Kelsey Mitch, RN · 412-623-6793 · adamkka2@upmc.edu
Always discuss trial participation with your own doctor first.
| Magee-Womens Research Institute / UPMC Magee Womens Hospital | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05942300